Miraflores, Peru Clinical Trials

A listing of Miraflores, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 96 clinical trials
A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

A global study to assess the efficacy and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non-small cell lung cancer

EGFR
lung carcinoma
osimertinib
cancer chemotherapy
growth factor
Research Site
 (1.5 away) Contact site
  • 207 views
  • 05 Sep, 2021
  • +154 other locations
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of pathological complete response.

EGFR
lung carcinoma
pemetrexed
cancer chemotherapy
carboplatin
Research Site
 (1.0 away) Contact site
  • 251 views
  • 02 Sep, 2021
  • +320 other locations
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Primary Objective: To evaluate the anti-leukemic activity of isatuximab in combination with standard chemotherapies in pediatric participants of ages 28 days to less than 18 years with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Acute Myeloid Leukemia (AML) Secondary Objectives: Safety and tolerability assessments Assessment of infusion reactions (IRs) Pharmacokinetics (PK) …

etoposide
cyclophosphamide
residual tumor
hydroxyurea
vincristine
Investigational Site Number 6040002
 (4.5 away) Contact site
  • 14 views
  • 14 Jun, 2021
  • +70 other locations
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

A global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab alone in patients with hepatocellular carcinoma who are at high risk of recurrence.

durvalumab
bevacizumab
Research Site
 (1.0 away) Contact site
  • 75 views
  • 22 Aug, 2021
  • +245 other locations
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Summit is developing ridinilazole as a novel antimicrobial for Clostridioides difficile Infection (CDI), formerly known as Clostridium difficile Infection, with the goal of achieving comparable cure rates to standard of care, but reducing rates of recurrent disease. A phase 2 proof of concept study, with vancomycin as comparator, demonstrated these …

vancomycin
diarrhea
antibiotic therapy
antibiotics
clostridium difficile
Hospital Nacional Edgardo Rebagliati Martins
 (2.5 away) Contact site
  • 101 views
  • 16 Apr, 2021
  • +257 other locations
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile Infection (CDI), formerly known as Clostridium difficile Infection, with the goal of achieving comparable cure rates to standard of care, but reducing rates of recurrent disease. A phase 2 proof of concept study, with vancomycin as comparator, demonstrated these …

vancomycin
diarrhea
antibiotic therapy
antibiotics
clostridium difficile
Hospital Nacional Edgardo Rebagliati Martins
 (2.5 away) Contact site
  • 18 views
  • 18 Apr, 2021
  • +181 other locations
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with BCG, compared to BCG monotherapy, in participants with HR NMIBC that is either persistent or recurrent following adequate BCG induction (Cohort A), or that is nave to BCG treatment (Cohort B). The primary hypothesis …

Oncosalud ( Site 0603)
 (1.5 away) Contact site
  • 108 views
  • 16 Sep, 2021
  • +141 other locations
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Phase III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple-negative Breast Cancer (TNBC)

triple-negative breast cancer
measurable disease
cancer
mammogram
breast cancer
Research Site
 (1.0 away) Contact site
  • 1387 views
  • 26 Aug, 2021
  • +309 other locations
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

The reason for the study is to find out if an experimental combination of an oral medication called osimertinib (TAGRISSO) when used in combination with chemotherapy is more effective than giving osimertinib alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due …

lung carcinoma
stage iv non-small cell lung cancer
non-squamous non-small cell lung cancer
epidermal growth factor receptor
cancer chemotherapy
Research Site
 (1.0 away) Contact site
  • 811 views
  • 12 Sep, 2021
  • +173 other locations
Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

This study will assess the safety and efficacy of cefepime/VNRX-5133 compared with meropenem in both eradication of bacteria and in symptomatic response in patients with cUTIs.

meropenem
acute pyelonephritis
pyelonephritis
cefepime
Site 160410
 (3.8 away) Contact site
  • 145 views
  • 28 Jun, 2021
  • +102 other locations